Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of levamlodipine besylate in hypertensive patients with renal insufficiency
ChiCTR2100053484Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Levamlodipine in hypertension (HTN), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Peak plasma drug concentration. Started Nov 2021; status: recruiting.
02
Drugs
Levamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2100053484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053484.